NAPT NEWS
For Immediate Release:
June 5, 2024 – Patients requiring radiation therapy for head and neck cancer benefit from proton therapy based on preliminary data from a multi-institution Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center. The results were presented today at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting by Steven Frank, M.D., professor of Radiation Oncology and executive director of the Particle Therapy Institute at The University of Texas MD Anderson Cancer Center.
The trial concluded that proton therapy was effective while producing fewer side effects, emerging as the standard of care treatment that reduces malnutrition and gastrostomy-tube dependence.
“This pivotal trial provides level-one evidence supporting the use of proton therapy for head and neck cancer and demonstrates the positive impact proton therapy can have on a patient’s health during and after treatment,” said Director Jennifer Maggiore, executive director of the National Association for Proton Therapy (NAPT). “This is significant because reducing side effects is valuable in supporting patient quality of life. Proton therapy can also lower payor costs and alleviate patient financial toxicity by reducing out-of-pocket spending and loss of income related to side effects.”
Of an estimated 71,100 people who will be diagnosed with head and neck cancer in 2024, only 2,200 – less than 5% – are likely to be treated with proton therapy, according to NAPT member data. Lack of access to proton therapy is often due to barriers including insurance prior authorizations and denials, which can lead to harmful delays in care.
“The numbers point to a need not only for greater access, but also to the imperative for additional patient, physician and payor education regarding the value of proton therapy,” said Maggiore. “NAPT will continue to advocate for more widespread adoption of proton therapy as the standard of care, while facilitating additional research that continues to prove the value of this life-saving, life-changing cancer treatment.”
# # #
The National Association for Proton Therapy (NAPT) is an independent nonprofit organization founded in 1990 to educate and increase awareness about the clinical benefits of proton therapy. Its members include 47 of the nation’s leading cancer centers, many of which are NCI-designated comprehensive cancer centers and NCCN members. The mission of NAPT is to work collaboratively to raise public awareness of the clinical benefits of proton therapy, ensure patient choice and access to affordable proton therapy, and encourage cooperative research and innovation to advance the appropriate and cost-effective utilization of proton therapy.
